Trial intelligence / Profile preview

Intensive lipid lowering and inflammation in stable coronary artery disease

2005-005084-29Phase 4Unknown

Sponsor
Chief Scientist Office
Start
Dec 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of atorvastatin in coronary arteriosclerosis (2 arms), sponsored by Chief Scientist Office. Status: unknown.

02

Drugs

atorvastatin
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on 2005-005084-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-005084-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call